Biotherapeutic formulations - Open Access .click

Results 131 to 140 of about 1,377,424 (162)

Some of the next articles are maybe not open access.

Shifting Perspectives on Biotherapeutic Treatment of Ulcerative Colitis using Lipid Mesophases: Formulation Design and Preclinical Validation

Abstract Biotherapeutics are required to achieve high remission rates in patients with severe ulcerative colitis (UC); however, adverse effects, complex dosing regimens, administration routes, and low patient compliance may limit their widespread clinical use.
Gazzi Rafaela +11 more
openaire +1 more source

Formulation and Device Lifecycle Management of Biotherapeutics

2022
openaire +1 more source

Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers

Cell Host and Microbe, 2022
Jason M Norman, Ed Kuijper, Jeremiah Faith +2 more
exaly

Discovery and delivery strategies for engineered live biotherapeutic products

Trends in Biotechnology, 2022
Nathan Crook, Aaron Anselmo
exaly

Treating Clostridioides difficile: Could Microbiota-based Live Biotherapeutic Products Provide the Answer?

Infection and Drug Resistance, 2023
Robert Orenstein
exaly

Microbiome-based informed method to formulate live biotherapeutics